Meet Blue Serenity, Canada’s First Natural Therapeutic Psilocybin Product For Approved Patients
The Canadian-based company licensed by Health Canada for psychedelic and functional mushrooms production, Optimi Health Corp.
Preclinical Trial Results Confirm Targeting Type 2 Cannabinoid Receptors Helps Relieve Sepsis-Related Condition
Tetra Bio-Pharma Inc. (OTCQB: TBPMF) (TSX:TBP) (FRA:JAM1) revealed positive preclinical results from live SARS-CoV-2 virus infection studies as well as a septic lung model, carried out by independent researchers.
Brittney Griner Prisoner Swap Looks Like Sophie’s Choice For Biden, Law Experts Offer Projections
Olympian and WNBA champion Brittney Griner was recently found guilty on drug charges and
Auxly Receives $4.1M on Sale Of Auxly Annapolis Outdoor Facility
Auxly Cannabis Group Inc. (TSX:XLY) ("Auxly" or the "Company"), a leading consumer packaged goods company in the cannabis products market, announced today that the Company has closed the sale of its
This Psychedelics Company Is Setting Up An Equity Program For Up To $35M In Shares
Cybin Inc. (NEO: CYBN) (NYSE: CYBN) has launched an at-the-market (ATM) equity program through which it will issue and sell up to $35 million in common shares in the company’s capital, from the treasury to the public.
Cannabis Reg. Updates: Wisconsin Pardons, Delta-8 Hemp Kentucky, Florida Legalization Initiative, NJ Weed Delivery
Wisconsin: More Pardons For Cannabis Offenses
COMPASS Pathways Sued For Alleged Theft Of Psilocybin Trade Secrets
Terran Biosciences Inc. is suing COMPASS Pathways (NASDAQ: CMPS) for the appropriation of trade secrets.
‘Missouri Marijuana Legalization Initiative Will Appear On November Ballot, State Announces’ -Marijuana Moment Report
https://www.marijuanamoment.net/missouri-marijuana-legalization-initiative-will-appear-on-november-ballot-state-announces/
EXCLUSIVE: Colombia Is About To Legalize Cannabis – And Exports May Land On Your Doorstep Soon, This CEO Says
Andres Fajardo is the CEO of Clever Leaves Holdings Inc. (NASDAQ: CLVR), one of the largest cannabis companies with operations in Canada, Colombia, Germany, Portugal and the United States.
MariMed Q2 Revenue Stagnates YoY, Provides Revised Financial Guidance
MariMed, Inc. (OTCQX: MRMD) (CSE:MRMD) released its financial results for the second quarter ended June 30, 2022, revealing revenue of $33 million, an increase of 1% compared to $32.6 million in Q2 2021.